O'Shaughnessy Asset Management, LLC Aurinia Pharmaceuticals Inc. Transaction History
O'Shaughnessy Asset Management, LLC
- $14.2 Billion
- Q2 2025
A detailed history of O'Shaughnessy Asset Management, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 21,021 shares of AUPH stock, worth $242,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,021
Previous 20,590
2.09%
Holding current value
$242,372
Previous $165,000
7.88%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AUPH
# of Institutions
244Shares Held
62.4MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$116 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$107 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$45.8 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$32.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$27.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.64B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...